Approach to Reduction of Blood Atherogenicity
We have earlier found that blood sera of patients with coronary heart disease (CHD) increase lipid levels in cells cultured from subendothelial intima of human aorta. We have also revealed that the ability of blood sera to raise intracellular cholesterol; that is, their atherogenicity is caused by a...
Main Authors: | Alexander N. Orekhov, Alexandra A. Melnichenko, Igor A. Sobenin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2014/738679 |
Similar Items
-
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
by: Volha I. Summerhill, et al.
Published: (2019-07-01) -
Atherogenic effect of systemic lupus erythematosus pts blood serum
by: Z S Alekberova, et al.
Published: (2003-06-01) -
Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
by: Alexander N. Orekhov, et al.
Published: (2014-07-01) -
The Interaction of Plasma Sialylated and Desialylated Lipoproteins with Collagen from the Intima and Media of Uninvolved and
Atherosclerotic Human Aorta
by: Igor A. Sobenin, et al.
Published: (2011-01-01) -
The effects of atherogenic dyslipidaemia on blood monocyte function
by: Jackson, William
Published: (2015)